Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1)

D-Praziquanamine (-)-2,3-Dibenzoyl-L-tartaric Acid is an intermediate in the synthesis of (R)-Praziquantel-d11 (P702102), Unlabeled (R)-Praziquantel-d11 (P702100) has been shown to exhibit antiparasitic activity; (R)-Praziquantel is the active enantiomer of praziquantel regarding activity against juvenile S. mansoni infestations in mice. (R)-Praziquantel exhibits Schistosoma mansoni infestation inhibition in vitro and in vivo.